跳至主要内容
临床试验/CTRI/2026/07/113685
CTRI/2026/07/113685进行中(未招募)3 期

A randomised controlled trial to compare efficacy of topical pilocarpine hydrogel 2 percent and triamcinolone acetonide oral paste 0.1 percent in the treatment of recalcitrant oral erosions in pemphigus vulgaris

DIPANKAR DE0 个研究点目标入组 30 人开始时间: 2026年7月20日最近更新:
干预措施

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • •Patients with diagnosis of pemphigus vulgaris fulfilling the inclusion criteria listed below will be recruited for the study
  • •Refractory oral pemphigus vulgaris has been arbitrarily defined for present study as less than 75 percent reduction in the objective component of oral pemphigus disease area index after being treated with optimal systemic immunosuppression and topical corticosteroids for at least 6 months with lesions at sites accessible to topical application including retro-molar trigone, buccal mucosa, gingiva, palate and lips.
  • •Patients between 18 to 60 years.
  • •Patients who are willing to provide informed consent and willing for follow-up.

排除标准

  • •Patients younger than 18 years and older than 60 years will be excluded.
  • •Prior hypersensitivity or contraindication for topical pilocarpine or triamcinolone will be excluded. These will include presence of active fungal eg oral candidiasis, viral eg herpes simplex, or bacterial infections, post-surgical or traumatic ulcers, undiagnosed lesions to prevent masking of serious conditions eg oral cancer.

研究组 & 干预措施

Intervention1: Institutionally compounded topical pilocarpine hydrogel 2%: The patients will be instructed to apply topical pilocarpine 2% hydrogel twice daily on all the accessible refractory lesions inside oral mucosa. The timings are arbitrarily selected as 11 AM and 6 PM, timepoints away from mealtimes, when salivation is least likely to wash away the topically applied drug.

干预措施: Intervention1: Institutionally compounded topical pilocarpine hydrogel 2%: The patients will be instructed to apply topical pilocarpine 2% hydrogel twice daily on all the accessible refractory lesions inside oral mucosa. The timings are arbitrarily selected as 11 AM and 6 PM, timepoints away from mealtimes, when salivation is least likely to wash away the topically applied drug.

研究者

发起方
DIPANKAR DE

相似试验

A study to compare efficacy of topical pilocarpine... | 临床试验